Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00361673 · ClinicalTrials.gov registry record
Evaluating the Effect of Neighborhood Environments on Cardiovascular Risk Factors
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 1,140
- Enrollment target
NCT00361673: Completed study, sponsored by University of Colorado, Denver.
NCT00361673 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 1,140 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00361673 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 1,140 participants
- Enrollment target
Study Summary
Cardiovascular disease (CVD) is one of the main causes of death in the United States. Research has shown that individuals who maintain an active lifestyle are less likely to develop CVD. This study will examine how neighborhood environments influence CVD risk factors of residents in and around the Stapleton community of Denver, Colorado.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,140 participants |
| Start Date | 2006-09 |
| Est. Completion | 2009-05 |
What the finished NCT00361673 record still lists
NCT00361673 is an observational study that tracks outcomes without assigning an intervention. Its 1,140 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00361673 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00361673 about?
NCT00361673 is a clinical study titled "Evaluating the Effect of Neighborhood Environments on Cardiovascular Risk Factors". Cardiovascular disease (CVD) is one of the main causes of death in the United States. Research has shown that individuals who maintain an active lifestyle are less likely to develop CVD. This study will examine how neighborhood environments influence CVD risk factors of residents in and around the S...
What is the current status of trial NCT00361673?
This trial is currently completed. The enrollment target is 1,140 participants. The study started on 2006-09. Estimated completion is 2009-05.
Who is sponsoring clinical trial NCT00361673?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05894967 · 1,140 participants · NA
Moderators and Mediators of Perceptual Learning
- NCT06532487 · 1,140 participants · NA
Addressing Durable Health Disparities Through Critical Time Legal Interventions in Medically Underserved Latinx and Migrant Communities
- NCT06129864 · 1,145 participants · Phase 3
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
- NCT06676319 · 1,147 participants · Phase 2
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia